The detailed analysis indeed revealed that the number of CD4+ effector memory T cells are higher in patients with mild COVID-19, whereas the number of MAIT/NKT increased with COVID-19 severity (Figure 7F, Supplementary Figure S24). This evidence concerns the gene CD4 and COVID-19.